Integrin-mediated resistance to epidermal growth factor receptor-targeted therapy: an inflammatory situation

por Brown, Wells S, Wendt, Michael K
Publicado 2014

The paradoxical functions of EGFR during breast cancer progression

por Ali, Remah, Wendt, Michael K
Publicado 2017

Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-β signaling and metastasis

por Wendt, Michael K, Schiemann, William P
Publicado 2009

FGFR signaling maintains a drug persistent cell population following epithelial-mesenchymal transition

por Brown, Wells S., Akhand, Saeed Salehin, Wendt, Michael K.
Publicado 2016

CXCL12 Chemokine Expression and Secretion Regulates Colorectal Carcinoma Cell Anoikis through Bim-Mediated Intrinsic Apoptosis

por Drury, Luke J., Wendt, Michael K., Dwinell, Michael B.
Publicado 2010

Transforming Growth Factor-β-Induced Epithelial-Mesenchymal Transition Facilitates Epidermal Growth Factor-Dependent Breast Cancer Progression

por Wendt, Michael K., Smith, Jason A., Schiemann, William P.
Publicado 2010

scTree: An R package to generate antibody-compatible classifiers from single-cell sequencing data

por Paez, J. Sebastian, Wendt, Michael K., Lanman, Nadia Atallah
Publicado 2020

In vivo Dual Substrate Bioluminescent Imaging

por Wendt, Michael K., Molter, Joseph, Flask, Christopher A., Schiemann, William P.
Publicado 2011

STAT3 and epithelial–mesenchymal transitions in carcinomas

por Wendt, Michael K, Balanis, Nikolas, Carlin, Cathleen R, Schiemann, William P
Publicado 2014

Pyruvate carboxylase supports the pulmonary tropism of metastatic breast cancer

por Shinde, Aparna, Wilmanski, Tomasz, Chen, Hao, Teegarden, Dorothy, Wendt, Michael K.
Publicado 2018

Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer

por Wendt, Michael K., Taylor, Molly A., Schiemann, Barbara J., Schiemann, William P.
Publicado 2011

β3 Integrin–EGF receptor cross-talk activates p190RhoGAP in mouse mammary gland epithelial cells

por Balanis, Nikolas, Yoshigi, Masaaki, Wendt, Michael K., Schiemann, William P., Carlin, Cathleen R.
Publicado 2011

Biased signaling downstream of epidermal growth factor receptor regulates proliferative versus apoptotic response to ligand

por Ali, Remah, Brown, Wells, Purdy, Stephen Connor, Davisson, V. Jo, Wendt, Michael K.
Publicado 2018

Regulation of epithelial-mesenchymal transition and metastasis by TGF-β, P-bodies, and autophagy

por Hardy, Shana D., Shinde, Aparna, Wang, Wen-Horng, Wendt, Michael K., Geahlen, Robert L.
Publicado 2017

Transglutaminase-2 facilitates extracellular vesicle-mediated establishment of the metastatic niche

por Shinde, Aparna, Paez, Juan Sebastian, Libring, Sarah, Hopkins, Kelsey, Solorio, Luis, Wendt, Michael K.
Publicado 2020

Fibroblast growth factor receptor splice variants are stable markers of oncogenic transforming growth factor β1 signaling in metastatic breast cancers

por Wendt, Michael K, Taylor, Molly A, Schiemann, Barbara J, Sossey-Alaoui, Khalid, Schiemann, William P
Publicado 2014

Increased Ammonium Toxicity in Response to Exogenous Glutamine in Metastatic Breast Cancer Cells

por Kiesel, Violet A., Sheeley, Madeline P., Donkin, Shawn S., Wendt, Michael K., Hursting, Stephen D., Teegarden, Dorothy
Publicado 2022

Transglutaminase-2 mediates acquisition of neratinib resistance in metastatic breast cancer

por Shinde, Aparna, Kulkoyluoglu Cotul, Eylem, Chen, Hao, Smith, Andrew, Libring, Sarah, Solorio, Luis, Wendt, Michael K.
Publicado 2022

SHP2 is a multifunctional therapeutic target in drug resistant metastatic breast cancer

por Chen, Hao, Libring, Sarah, Ruddraraju, Kasi Viswanatharaju, Miao, Jinmin, Solorio, Luis, Zhang, Zhong-Yin, Wendt, Michael K.
Publicado 2020

Fibroblast growth factor receptor facilitates recurrence of minimal residual disease following trastuzumab emtansine therapy

por Akhand, Saeed S., Chen, Hao, Purdy, Stephen Connor, Liu, Zian, Anderson, Joshua C., Willey, Christopher D., Wendt, Michael K.
Publicado 2021